Resolution of Pain after Percutaneous Image-Guided Cryoablation of Extraperitoneal Endometriosis.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
07 2023
Historique:
received: 27 10 2022
revised: 15 02 2023
accepted: 22 03 2023
pmc-release: 01 07 2024
medline: 30 6 2023
pubmed: 2 4 2023
entrez: 1 4 2023
Statut: ppublish

Résumé

To retrospectively evaluate the relief of pain after percutaneous image-guided cryoablation of symptomatic extraperitoneal endometriosis (EE). From 2017 to 2022, cryoablation of EE was performed at a single institution on a total of 47 lesions in 42 consecutive patients (median age, 37 years; interquartile range [IQR], 33-39.5 years). Patient and procedural characteristics were reviewed retrospectively. Tolerance and outcomes in terms of pain and patient satisfaction were evaluated. The median follow-up duration was 13.5 months (IQR, 1.1-37.7 months) after cryoablation. The median pain-free survival rate was 93.8% (95% confidence interval [CI], 77.3-98.4) at 6 months and 82.7% (95% CI, 58.8-93.5) after 12 months. Pain decreased from a median of 8/10 (IQR, 7-9) on the visual analog scale to 0/10 (IQR, 0-1) at the last follow-up (P < .0001). The median Patient Global Impression of Change score recorded at the last follow-up was 1/7 (IQR, 1-2). The efficacy rate of cryoablation to avoid secondary surgery was 92.8% (39/42) per patient and 93.6% (44/47) per nodule treated. Four patients (9.5%, 4/42) experienced an adverse event in the days following the procedure, and 1 patient (2%) experienced a severe adverse event. Percutaneous cryoablation is safe and effective in significantly reducing pain and obtaining local control of EE.

Identifiants

pubmed: 37003579
pii: S1051-0443(23)00259-2
doi: 10.1016/j.jvir.2023.03.025
pmc: PMC10625427
mid: NIHMS1939741
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1192-1198

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2023 SIR. Published by Elsevier Inc. All rights reserved.

Références

J Vasc Interv Radiol. 2013 Dec;24(12):1817-25
pubmed: 24060437
Eur Radiol. 2010 May;20(5):1267-76
pubmed: 19936757
Am J Surg. 2008 Aug;196(2):207-12
pubmed: 18513698
Eur Radiol. 2017 Oct;27(10):4298-4306
pubmed: 28396995
Radiology. 2000 Jun;215(3):783-90
pubmed: 10831700
Am J Obstet Gynecol. 2019 Apr;220(4):354.e1-354.e12
pubmed: 30625295
Diagn Interv Imaging. 2013 Apr;94(4):364-70
pubmed: 23491212
N Engl J Med. 2020 Mar 26;382(13):1244-1256
pubmed: 32212520
Hum Reprod. 2013 Jun;28(6):1552-68
pubmed: 23528916
AJR Am J Roentgenol. 2006 Mar;186(3):616-20
pubmed: 16498086
J Am Assoc Gynecol Laparosc. 2003 Feb;10(1):17-26
pubmed: 12554989
Data Brief. 2016 Feb 05;6:1007-15
pubmed: 26958632
Int J Hyperthermia. 2015 May;31(3):280-4
pubmed: 25609456
J Vasc Interv Radiol. 2013 Jun;24(6):823-7
pubmed: 23707090
Skeletal Radiol. 2010 Feb;39(2):175-82
pubmed: 19768644
Abdom Radiol (NY). 2022 Aug;47(8):2669-2673
pubmed: 34773468
Eur J Anaesthesiol. 2016 Nov;33(11):853-865
pubmed: 27635953
Diagn Interv Imaging. 2023 Mar;104(3):95-112
pubmed: 36404224
Int J Gynaecol Obstet. 2005 Apr;89(1):59-60
pubmed: 15777905
Cardiovasc Intervent Radiol. 2015 Oct;38(5):1171-8
pubmed: 25823573
J Vasc Interv Radiol. 2023 Jan;34(1):1-3
pubmed: 36244632
J Vasc Interv Radiol. 2012 Aug;23(8):1101-3
pubmed: 22840810
Skeletal Radiol. 2009 Sep;38(9):835-9
pubmed: 19590871
Semin Intervent Radiol. 2010 Sep;27(3):276-84
pubmed: 22550367
Abdom Radiol (NY). 2020 Jun;45(6):1813-1817
pubmed: 31894380
Cardiovasc Intervent Radiol. 2014 Dec;37(6):1575-9
pubmed: 24464261
Ann Plast Surg. 1998 Jun;40(6):672-5
pubmed: 9641291
Clin Hemorheol Microcirc. 2022;82(1):63-73
pubmed: 35662109
Am J Surg. 2003 Jun;185(6):596-8
pubmed: 12781893
Cardiovasc Intervent Radiol. 2013 Jun;36(3):853-6
pubmed: 22722720
J Minim Invasive Gynecol. 2021 Nov;28(11):1849-1859
pubmed: 34690084
BJU Int. 2005 Dec;96(9):1224-9
pubmed: 16287435
Cardiovasc Intervent Radiol. 2009 Nov;32(6):1300-3
pubmed: 19184197
J Vasc Interv Radiol. 2009 Dec;20(12):1527-40
pubmed: 19864161
Cardiovasc Intervent Radiol. 2014 Dec;37(6):1500-6
pubmed: 24402645
J Urol. 2005 Apr;173(4):1368-74
pubmed: 15758807
Nat Rev Cancer. 2014 Mar;14(3):199-208
pubmed: 24561446
AJR Am J Roentgenol. 2017 Sep;209(3):690-696
pubmed: 28609130
Tech Vasc Interv Radiol. 2011 Sep;14(3):170-6
pubmed: 21767784
J Pain. 2015 Jun;16(6):518-26
pubmed: 25746196
BJOG. 2017 Aug;124 Suppl 3:59-63
pubmed: 28856852

Auteurs

Milan Najdawi (M)

Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.

Leo Razakamanantsoa (L)

Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.

Cyril Mousseaux (C)

Department of Nephrology, Tenon Hospital, Sorbonne University, Paris, France.

Sofiane Bendifallah (S)

Department of Gynecology, Tenon Hospital, Sorbonne University, Paris, France.

Cyril Touboul (C)

Department of Gynecology, Tenon Hospital, Sorbonne University, Paris, France.

Isabelle Thomassin-Naggara (I)

Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.

Marc Bazot (M)

Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.

Matthias Barral (M)

Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France.

Francois H Cornelis (FH)

Department of Interventional Radiology and Oncology, Tenon Hospital, Sorbonne University, Paris, France; Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: cornelisfrancois@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH